Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54.3M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
51.2M
-
Shares change
-
+2.62M
-
Total reported value, excl. options
-
$475M
-
Value change
-
-$6.69M
-
Number of buys
-
76
-
Number of sells
-
-34
-
Price
-
$9.29
Significant Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) as of Q2 2025
124 filings reported holding BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.2M shares
of 54.3M outstanding shares and own 94.14% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.96M shares), Siren, L.L.C. (5.22M shares), Vestal Point Capital, LP (5M shares), RED TREE MANAGEMENT, LLC (3.17M shares), TPG GP A, LLC (3.01M shares), FMR LLC (2.54M shares), Deep Track Capital, LP (2.43M shares), Omega Fund Management, LLC (2.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.15M shares), and BlackRock, Inc. (2.11M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.